This invention relates to novel tetrahydroisoquinoline derivatives, their derivatives, pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a dual OX-1/OX-2 orexin antagonist.
The invention relates to compounds of Formula I or Ia as disclosed herein:
or pharmaceutically acceptable salts thereof or tautomers thereof.
US8084464B2
申请人:——
公开号:US8084464B2
公开(公告)日:2011-12-27
US8575221B2
申请人:——
公开号:US8575221B2
公开(公告)日:2013-11-05
[EN] DERIVATIVES OF DIMETHYLCURCUMIN<br/>[FR] DÉRIVÉS DE DIMÉTHYLCURCUMINE
申请人:CONCERT PHARMACEUTICALS INC
公开号:WO2011116066A1
公开(公告)日:2011-09-22
The invention relates to compounds of Formula (I) or (Ia), which are depicted herein, or pharmaceutically acceptable salts thereof or tautomers thereof.